Sandra Lassalle Selected Research

Sandra Lassalle Research Topics

20	Neoplasms (Cancer) 04/2022 - 09/2007
7	Melanoma (Melanoma, Malignant) 12/2021 - 05/2015
6	Papillary Thyroid Cancer 05/2014 - 11/2009
5	Thyroid Neoplasms (Thyroid Cancer) 05/2016 - 06/2006
4	Lung Neoplasms (Lung Cancer) 02/2019 - 04/2016
4	Adenocarcinoma of Lung 01/2019 - 02/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 01/2018
2	Uveal melanoma 12/2021 - 01/2021
2	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2021
2	COVID-19 12/2021 - 12/2020
1	Immune Reconstitution Inflammatory Syndrome 05/2021
1	Thyroid Diseases (Thyroid Disease) 01/2021
1	Margins of Excision 01/2019
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2016
1	Hypoxia (Hypoxemia) 09/2013
1	Colonic Neoplasms (Colon Cancer) 02/2013
1	Follicular Adenocarcinoma 10/2011
1	Hyperplasia 11/2009
1	Carcinoma (Carcinomatosis) 11/2009
1	Crohn Disease (Crohn's Disease) 06/2009
1	Hand-Foot Syndrome 07/2008
1	Gram-Negative Bacterial Infections 09/2007
1	Gastritis 06/2007
1	Tuberculosis (Tuberculoses) 12/2006
1	Granuloma 12/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2006
1	HIV Infections (HIV Infection) 09/2005
1	Lipodystrophy 09/2005

7	Biomarkers (Surrogate Marker)IBA 12/2021 - 03/2018
6	Biological ProductsIBA 11/2021 - 10/2010
4	Immune Checkpoint InhibitorsIBA 01/2021 - 12/2016
4	Formaldehyde (Formol)FDA Link 11/2017 - 12/2006
3	DNA (Deoxyribonucleic Acid)IBA 06/2018 - 12/2006
3	ParaffinIBA 11/2017 - 12/2006
3	MicroRNAs (MicroRNA)IBA 05/2016 - 10/2011
2	Hematoxylin (Haematoxylon)IBA 03/2022 - 12/2006
2	Eosine Yellowish-(YS) (Eosin)IBA 03/2022 - 12/2006
2	Indicators and Reagents (Reagents)IBA 12/2021 - 12/2016
2	Monoclonal AntibodiesIBA 12/2016 - 05/2015
2	Proteins (Proteins, Gene)FDA Link 09/2013 - 01/2010
2	Uridine Monophosphate (UMP)IBA 10/2011 - 07/2009
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	pembrolizumabIBA 01/2018
1	N 30IBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 05/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2015
1	Carbonic Anhydrase IXIBA 09/2013
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2013
1	Lactalbumin (alpha-Lactalbumin)IBA 12/2011
1	Vorinostat FDA Link 12/2011
1	Etoposide (VP 16)FDA LinkGeneric 12/2011
1	Histones (Histone)IBA 12/2011
1	trichostatin A (A 300)IBA 12/2011
1	Histone Deacetylase InhibitorsIBA 12/2011
1	RacivirIBA 10/2011
1	Fixatives (Pickling Agents)IBA 11/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2009
1	Capecitabine (Xeloda)FDA Link 07/2008
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2007
1	Pharmaceutical PreparationsIBA 06/2007

8	Therapeutics 04/2022 - 09/2005
5	Immunotherapy 12/2021 - 04/2016
3	Highly Active Antiretroviral Therapy (HAART) 05/2021 - 09/2005
1	Organ Transplantation 05/2021
1	Precision Medicine 01/2021
1	Proton Therapy 12/2019
1	Cryotherapy (Therapy, Cold) 12/2019
1	Molecular Targeted Therapy 02/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Lasers (Laser) 12/2006
1	Thyroidectomy 06/2006